diamicron mr gliclazide modified release tablet 60mg per tablet 30tablets per carton

Description

Indication & Scope

Diamicron MR® is a prescription sulfonylurea indicated as an adjunct to diet, exercise, and weight management to improve glycemic control in adults with type 2 diabetes mellitus when lifestyle measures alone are insufficient. It may be used as monotherapy or in combination with other antidiabetic agents, including metformin, DPP-4 inhibitors, and insulin. The modified-release formulation provides sustained glucose-lowering effects with once-daily dosing.

Mechanism: Gliclazide stimulates insulin secretion from functional pancreatic β-cells by closing ATP-sensitive potassium channels, thereby reducing blood glucose levels.
Drug class: Second-generation sulfonylurea.
Clinical use: Monotherapy or combination therapy for adults with type 2 diabetes mellitus requiring improved glycemic control.

Specification

Generic Name	Gliclazide Modified-release Tablets
Brand Name	Diamicron MR®
Ingredient	Gliclazide
Dosage Form	Modified-release tablet
Package	60 mg/tablet, 30 tablets/carton
Conditions Treated	Adults with type 2 diabetes mellitus requiring improved glycemic control when diet, exercise, and weight reduction alone are insufficient, either as monotherapy or in combination with other antidiabetic medications.
Taboos	Hypersensitivity to gliclazide, sulfonylureas, or sulfonamides; type 1 diabetes mellitus; diabetic ketoacidosis; severe renal or hepatic impairment.
Place of origin	France
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 30°C in a dry place, protected from moisture.
Manufacturer	Les Laboratoires Servier Industrie
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	HJ20150282
Approval Date	March 20, 2024
Shelf Life	36 months

How to use ?

Recommended Dose: The usual starting dose is 60 mg once daily with breakfast. The dose may be adjusted according to blood glucose response, up to 120 mg once daily.

Time: Take once daily with breakfast.

Instructions for use: Swallow the tablet whole. Do not crush, chew, or split the tablet. Continue dietary and lifestyle management during treatment.

Interaction: The risk of hypoglycemia increases when combined with insulin or other glucose-lowering agents. Corticosteroids and some diuretics may reduce its glucose-lowering effect.

Side effects: Common adverse reactions include hypoglycemia, nausea, abdominal discomfort, dizziness, headache, and skin rash.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support